-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIACELL THERAPEUTICS CORP - DSMB RECOMMENDS CONTINUATION OF BRIACELL PHASE 3 STUDY WITH NO SAFETY CONCERNS

Reuters·05/26/2026 11:30:05

Please log in to view news